...I'm Matthew Harrison, one of the biopharma analysts here at Morgan Stanley. Very pleased to have Sarepta with us for the next session. Before we get started, I need to read a disclosure statement. Please note that all important disclosures, including personal holdings disclosures and Morgan Stanley disclosures appear on the Morgan Stanley public website at morganstanley.com/research disclosures. And so with that, very pleased to have Doug Ingram, I'm the CEO; and Ian Estepan, the CFO from Sarepta. Doug, I'm going to turn it over to you to make some opening comments, and then we can get into Q&A. Ian Michael Estepan ...